May 24, 2017 - AstraZeneca plc (AZN) announced top-line results from the EXSCEL study evaluating the cardiovascular (CV) safety profile of its type II diabetes drug Bydureon.
May 24, 2017 - Merck & Co., Inc. (MRK) announced that Keytruda, has received accelerated approval for the treatment of microsatellite instability-high (MSI-H) or mismatch repair deficient solid tumors .
May 23, 2017 - Merck & Co Inc. (NYSE:MRK) Annual Shareholders Meeting Conference May 23, 2017, 09:00 AM ET Executives Ken Frazier - Chairman and CEO Amy Klug - Executive Director, IR and Assistant Secretary Roge
May 23, 2017 - Merck (MRK) presented data from a phase II study on its pipeline candidate MK-7264 (formerly AF-219) at the American Thoracic Society (ATS) Annual Conference.
May 22, 2017 - Novartis (NVS) recently announced that the CHMP of the European Medicines Agency (EMA) has recommended the approval of a label expansion of Zykadia.
May 22, 2017 - Merck (MRK) and Sanofi (SNY) are both Zacks Rank #2 (Buy) stocks. Which company looks better-positioned for the remainder of the year?
May 22, 2017 - A late-stage study at Amgen, Inc. (AMGN) showed that its pipeline candidate Evenity/romosozumab led to a statistically significant superior fracture risk reduction.
May 22, 2017 - Merck & Co., Inc. (MRK) recently announced that the 600 mg film-coated formulation of its marketed drug, Isentress (raltegravir) in combination with other anti-retroviral therapies, has received positive opinion from CHMP.
May 21, 2017 - Looking for top animal-health companies to buy? Check out Zoetis, Merck, and Lilly.
May 19, 2017 - Companies in the News are: